Scapular DyskinesisNCT07681999
Study of Early Scapular Dyskinesis
An observational study of Scapular Dyskinesis, run by Tanta University at 1 site in Egypt.
Trial summary
This study is a prospective blind study of periscapular muscle thickness measured with MSUS and correlate it with EMG findings. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Scapular Dyskinesis
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 19 Jun 2026to Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: * The first group: patients with SD with inflammatory characteristics. * The second group: patients with SD complaining of discomfort upon activity.
Who may be able to join
- The inclusion criterion for the first group is patients with SD with inflammatory characteristics.
- The inclusion criterion for the second group is patients complaining of discomfort upon activity.
Who cannot join
- The exclusion criteria of the first group included:
- patients with a history of local trauma
- patients with surgical intervention,
- neuromascular deficits,
- chronic chest disease
- a history of AS or
- other systemic autoimmune/ rheumatologic disease.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Faculty of medicine, Tanta University
Tanta
Aliaa Mamdouh Abdelaziz Farag, +201069468486, aliaa.mamdouh@med.tanta.edu.eg
About this study
Official title: Cross Sectional Study of Early Scapular Dyskinesis
This study is a prospective blind study of periscapular muscle thickness measured with MSUS and correlate it with EMG findings.
- Conditions
- Scapular Dyskinesis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| patients with dyskinesis with Inflammatory characteristics | patients with dyskinesis with Inflammatory characteristics | |
| Mechanical dyskinesis group | patients with dyskinesis with mechanical characteristics |
What is being measured
The primary outcome is the main question the study is designed to answer.
periscapular muscle thickness measured with MSUS in all patients
Measurement of periscapular muscle thickness with MSUS in all patients and to correlate it with EMG findings.
Measured: day 1 (At the same time of initial examination)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2026
- Study start19 Jun 2026
- Primary completionSep 2026 (estimated)
- Study completionSep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Scapular DyskinesisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aliaa Mamdouh Abdelaziz Farag, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07681999
- Sponsor's protocol ID
- 36264PR770/7/24
- Status last verified
- Jun 2026
- First submitted
- 27 Jun 2026
- Last updated
- 30 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Plan to Share IPD: "Yes"Plan Description: "Data obtained through this study may be provided to qualified researchers with academic interest in scapular dyskinesis. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e., a material transfer agreement) are prerequisites to the sharing of data with the requesting party.Results will be published by the investigators in academic journal.
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cross Sectional Study of Early Scapular Dyskinesis
- ClinicalTrials.gov ID
- NCT07681999
- Acronym / sponsor ID
- 36264PR770/7/24
- Conditions
- Scapular Dyskinesis
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 19 Jun 2026 (actual)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Sep 2026 (estimated)
- First posted
- 2 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a prospective blind study of periscapular muscle thickness measured with MSUS and correlate it with EMG findings.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| patients with dyskinesis with Inflammatory characteristics | – | –patients with dyskinesis with Inflammatory characteristics |
| Mechanical dyskinesis group | – | –patients with dyskinesis with mechanical characteristics |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- * The first group: patients with SD with inflammatory characteristics. * The second group: patients with SD complaining of discomfort upon activity.
Key inclusion criteria (2 listed)
- The inclusion criterion for the first group is patients with SD with inflammatory characteristics.
- The inclusion criterion for the second group is patients complaining of discomfort upon activity.
Key exclusion criteria (7 listed)
- The exclusion criteria of the first group included:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
periscapular muscle thickness measured with MSUS in all patients
Time frame: day 1 (At the same time of initial examination)
Measurement of periscapular muscle thickness with MSUS in all patients and to correlate it with EMG findings.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2026.
- Individual participant dataSharing planned: Yes. Plan to Share IPD: "Yes"Plan Description: "Data obtained through this study may be provided to qualified researchers with academic interest in scapular dyskinesis. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e., a material transfer agreement) are prerequisites to the sharing of data with the requesting party.Results will be published by the investigators in academic journal.
Related trials for Scapular Dyskinesis
Active, not recruiting
Scapular Stabilization Versus Proprioceptive Neuromuscular Facilitation Technique in Scapular Dyskinesis
Scapular Dyskinesis
RecruitingObservational study
Relation Between Swimming Stroke Types And Scapular Dyskinesia In Swimmers: A Cross - Sectional Study
Scapular Dyskinesis, Scapuloshoulder Disorders
Recruiting
Routine Rehabilitation Versus Shock Wave Therapy for Scapular Dyskinesis
Scapular Dyskinesis, Shockwave Therapy
Recruiting
Effects of Motor Control Retraining and Scapular Stabilization Exercises in Females With Scapular Dyskinesia.
Scapular Dyskinesis
RecruitingObservational study
Morphological Changes of Upper Trapezius Muscle After Physotherapy in Oral Cancer
Oral Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Scapular Dyskinesis, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aliaa Mamdouh Abdelaziz Farag, MD (+201069468486, aliaa.mamdouh@med.tanta.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
periscapular muscle thickness measured with MSUS in all patients (time frame: day 1 (At the same time of initial examination)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.